Biological and biosimilar medicines

Home / Medicines

Discover the portfolio of biological and biosimilar medicines produced and distributed by us for the entire population.

Hematology

Pegtima® (pegfilgrastim)

Medicine indicated to stimulate the production of white blood cells in the bone marrow, helping to prevent infections in patients undergoing certain treatments, such as chemotherapy.

Immunology

Adalimumab

Medication indicated for the treatment of autoimmune diseases, such as Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis and polyarticular juvenile idiopathic arthritis.

Interferon beta-1a

Medicine indicated for the treatment of Multiple Sclerosis.

Etanercept

Medicine indicated for the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis and ankylosing spondylitis.

Golimumab

Medicine indicated for the treatment of rheumatoid arthritis.

Infliximab

Medicine indicated for the treatment of autoimmune diseases, such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis.

Oncology

Bevanovis (Bevacizumab)

Bevacizumab is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels (angiogenesis). It is indicated for the treatment of various diseases, especially several types of cancer, including: Metastatic colorectal cancer, Advanced or metastatic non-small cell lung cancer, Metastatic breast cancer, Metastatic kidney cancer (advanced renal cell carcinoma), Advanced or recurrent ovarian, fallopian tube and primary peritoneal cancer, Persistent, recurrent or metastatic cervical cancer.

Rituximab

Medicine indicated for the treatment of non-Hodgkin’s lymphoma, chronic lymphoblastic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis.

Trastuzumab

Medicine indicated for the treatment of early breast cancer, metastatic and non-metastatic breast cancer and advanced gastric cancer.

Diseases and conditions

Find out more about your diagnosis and available treatment alternatives.

Biological and biosimilar medicines

Hematology

Immunology

Adalimumab

Interferon beta-1a

Etanercept

Golimumab

Infliximab

Oncology

Rituximab

Trastuzumab

Diseases and conditions

Science

About us

Transparency and Equal Pay Report for Women and Men

Medicine

Institucional

GPDPL